Guardian Pharmacy Services, Inc. - CLASS A COMMON STOCK (GRDN)

CUSIP: 40145W101

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / CLASS A COMMON STOCK
Total 13F shares
18,189,989
Total 13F value
$387,569,002
Holder snapshot 6 signals
Share change
+8,509,327
SEC-reported price per share
$21.31
Number of holders
105
Value change
+$181,272,786
Number of buys
81
Number of sells
16
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
36,297,796

Security key

40145W101

Report period

Q2 2025

Institutions

105

Top holders

10

GRDN full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Guardian Pharmacy Services, Inc. SEC filings Guardian Pharmacy Services, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GRDN - Guardian Pharmacy Services, Inc. - CLASS A COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
BROWN ADVISORY INC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F Lead comparable stake: 4.7% 13D/G row: Alyeska Investment Group, L.P. Showing 1-6 of 15 holder rows.

Quick read

Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 4.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership Top 5
Alyeska Investment Group, L.P. 4.7%
Woodline Partners LP 4.5%
FRANKLIN RESOURCES INC 4.3%
VANGUARD GROUP INC 4.2%
TIAA CREF INVESTMENT MANAGEMENT LLC 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Alyeska Investment Group, L.P.
13D/G 13F
Company
13D/G 13F
4.7%
$10,328,537
428,570 shares
 $0 31 Dec 2024
Woodline Partners LP
13D/G 13F
Company
13D/G 13F
4.5%
$10,004,392
415,120 shares
 $0 31 Dec 2024
FRANKLIN RESOURCES INC
13D/G 13F
Company
13D/G 13F
4.3%
$19,914,623
976,207 shares
 +$4,847,652 30 Jun 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
13D/G 13F
4.2%
$20,602,636
966,806 shares
 +$7,853,289 30 Jun 2025
TIAA CREF INVESTMENT MANAGEMENT LLC
13D/G
13D/G
2.1%
$11,531,175
467,986 shares
 $0 30 May 2025
Clearbridge Investments, LLC
13F 13D/G
Company
13F 13D/G
2%
from 13D/G
$10,860,458
510,840 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
105
Shares
18,189,989
Rows available
105
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
74
Q2 2025 holders
105
Holder diff
31
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .